193 related articles for article (PubMed ID: 12533829)
21. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
Chawengchao B; Petmitr S; Ponglikitmongkol M; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Anticancer Res; 2001; 21(4A):2739-43. PubMed ID: 11724349
[TBL] [Abstract][Full Text] [Related]
22. Epithelial and stromal genetic instability linked to tumor suppressor genes in ulcerative colitis-associated tumorigenesis.
Yagishita H; Yoshida T; Ishiguro K; Numata Y; Okayasu I
Scand J Gastroenterol; 2008; 43(5):559-66. PubMed ID: 18415748
[TBL] [Abstract][Full Text] [Related]
23. Clonality, founder mutations, and field cancerization in human ulcerative colitis-associated neoplasia.
Leedham SJ; Graham TA; Oukrif D; McDonald SA; Rodriguez-Justo M; Harrison RF; Shepherd NA; Novelli MR; Jankowski JA; Wright NA
Gastroenterology; 2009 Feb; 136(2):542-50.e6. PubMed ID: 19103203
[TBL] [Abstract][Full Text] [Related]
24. Matrilysin (matrix metalloproteinase-7) expression in ulcerative colitis-related tumorigenesis.
Newell KJ; Matrisian LM; Driman DK
Mol Carcinog; 2002 Jun; 34(2):59-63. PubMed ID: 12112311
[TBL] [Abstract][Full Text] [Related]
25. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease.
Hussain SP; Amstad P; Raja K; Ambs S; Nagashima M; Bennett WP; Shields PG; Ham AJ; Swenberg JA; Marrogi AJ; Harris CC
Cancer Res; 2000 Jul; 60(13):3333-7. PubMed ID: 10910033
[TBL] [Abstract][Full Text] [Related]
26. p53 immunohistochemistry of ulcerative colitis-associated with dysplasia and carcinoma.
Sato A; MacHinami R
Pathol Int; 1999 Oct; 49(10):858-68. PubMed ID: 10571818
[TBL] [Abstract][Full Text] [Related]
27. Midkine expression in colorectal tumors: correlation with Ki-67 labeling in sporadic, but not ulcerative colitis-associated ones.
Tokuyama W; Mikami T; Fujiwara M; Matsui T; Okayasu I
Pathol Int; 2007 May; 57(5):260-7. PubMed ID: 17493173
[TBL] [Abstract][Full Text] [Related]
28. [p53 gene mutation in cancer of the colon and rectum].
Roa JC; Roa I; Melo A; Araya JC; Villaseca MA; Flores M; Schneider B
Rev Med Chil; 2000 Sep; 128(9):996-1004. PubMed ID: 11349504
[TBL] [Abstract][Full Text] [Related]
29. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
30. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of the p14(ARF) gene in ulcerative colitis-associated colorectal carcinogenesis.
Sato F; Harpaz N; Shibata D; Xu Y; Yin J; Mori Y; Zou TT; Wang S; Desai K; Leytin A; Selaru FM; Abraham JM; Meltzer SJ
Cancer Res; 2002 Feb; 62(4):1148-51. PubMed ID: 11861396
[TBL] [Abstract][Full Text] [Related]
32. Morphological Classification of Corrupted Colonic Crypts in Ulcerative Colitis.
Rubio CA; Schmidt PT
Anticancer Res; 2018 Apr; 38(4):2253-2259. PubMed ID: 29599347
[TBL] [Abstract][Full Text] [Related]
33. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
[TBL] [Abstract][Full Text] [Related]
34. The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis.
Noffsinger AE; Miller MA; Cusi MV; Fenoglio-Preiser CM
Cancer; 1996 Dec; 78(11):2307-12. PubMed ID: 8940999
[TBL] [Abstract][Full Text] [Related]
35. Altered expression of MUTYH and an increase in 8-hydroxydeoxyguanosine are early events in ulcerative colitis-associated carcinogenesis.
Gushima M; Hirahashi M; Matsumoto T; Fujita K; Fujisawa R; Mizumoto K; Nakabeppu Y; Iida M; Yao T; Tsuneyoshi M
J Pathol; 2009 Sep; 219(1):77-86. PubMed ID: 19479711
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
[TBL] [Abstract][Full Text] [Related]
37. Molecular profiling of ulcerative colitis-associated neoplastic progression.
Colliver DW; Crawford NP; Eichenberger MR; Zacharius W; Petras RE; Stromberg AJ; Galandiuk S
Exp Mol Pathol; 2006 Feb; 80(1):1-10. PubMed ID: 16277983
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
[TBL] [Abstract][Full Text] [Related]
39. High-grade dysplastic adenoma-like mass lesions are not an indication for colectomy in patients with ulcerative colitis.
Blonski W; Kundu R; Furth EF; Lewis J; Aberra F; Lichtenstein GR
Scand J Gastroenterol; 2008; 43(7):817-20. PubMed ID: 18584520
[TBL] [Abstract][Full Text] [Related]
40. [The status of p53 gene in the primary retinoblastoma].
Huang Q
Zhonghua Yan Ke Za Zhi; 1999 Jul; 35(4):248-51. PubMed ID: 11835813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
